New NIH funding for studies of suspicious microbes will accelerate solving Alzheimer’s disease

New government research grant funds targeted at infectious agents will accelerate investigations into the possible roles of germs in triggering or promoting Alzheimer’s disease”, says Leslie Norins, MD, PhD, CEO of Alzheimer’s Germ Quest, Inc.

The new monies were made known to scientists through a Funding Opportunity Announcement […]

2019-04-08T18:14:28+00:00 April 8, 2019|News|

NIA Advisory Council deems Alzheimer’s microbes an “Approved Concept” to receive research grant funds

At its most recent meeting the National Advisory Council on Aging (NACA), which advises NIH’s National Institute of Aging, took official note of the accumulated and expanding number of research reports that microbes may be playing an important role in the etiology of Alzheimer’s disease by elevating that topic to […]

2019-03-15T15:18:37+00:00 March 18, 2019|News|

Alzheimer’s Germ Quest has joined the ACT-AD coalition for accelerating development of Alzheimer’s disease therapies, reports Dr. Leslie Norins

Alzheimer’s Germ Quest, Inc., has become a member of the national coalition Accelerate Cure/Treatments for Alzheimer’s Disease, announces Leslie Norins, MD, PhD, CEO of Alzheimer’s Germ Quest.

Familiarly known as ACT-AD, the coalition is a group of more than 50 national organizations, chaired by the Alliance for Aging Research.  The coalition’s mission is making the […]

2019-02-11T16:02:53+00:00 February 11, 2019|News|

8 Videos Provide a Quick Way to Understand the Role of Germs in Alzheimer’s Disease

A set of eight one-minute videos released by Alzheimer’s Germ Quest, Inc. answers basic questions about the possibility Alzheimer’s disease might be triggered by an infectious agent.

Video topics include microbes in the brain, the role of plaques and inflammation, possible evidence of transmittal, infections that can take years […]

2019-01-31T14:07:07+00:00 January 31, 2019|News|

New Scientist article sheds light on role of porphyromonas gingivalis in Alzheimer’s

The recent online article in New Scientist, “We may finally know what causes Alzheimer’s – and how to stop it,” by Debora MacKenzie is fueling many discussions around the internet and within the infectious disease research industry. These conversations discuss the results of research by Cortexyme that a new drug to […]

2019-01-25T11:22:32+00:00 January 25, 2019|News|